Also known as Duract, Xibrom, and Bromday
Bromfenac is a non-steroidal anti-inflammatory drug (NSAID) marketed in the US as an ophthalmic solution (current brand name Bromday, prior formulation brand name Xibrom, which has since been discontinued.) by ISTA Pharmaceuticals for short-term, local use. Bromday® is the once-daily formulation of bromfenac, while Xibrom®, which has since been discontinued, was the twice-daily formulation. Bromfenac is indicated for the treatment of ocular inflammation and pain after cataract surgery, though it may be prescribed in an off-label manner by the physician.Source: Wikipedia
Estimated Total Cost: $198.11 for an average of 28 days supply
Patients are most commonly prescribed bromfenac to treat diabetes, blastomycosis, rabies, and west nile virus.